Contineum Therapeutics (CTNM) Shares Issued (2023 - 2025)

Contineum Therapeutics' Shares Issued history runs 3 years deep, the most recent figure standing at $5.6 million for Q3 2025.

• On a quarterly basis, Shares Issued rose 35.16% year-over-year to $5.6 million in Q3 2025; TTM through Sep 2025 was $5.6 million, a 35.16% increase from a year earlier, with the FY2024 full-year figure at $2.1 million, down 20.93% from the prior year.
• Shares Issued held at $5.6 million in Q3 2025 per CTNM's latest filing, from $5.6 million in the prior quarter.
• Across five years, Shares Issued topped out at $5.6 million in Q3 2025 and bottomed at $2.1 million in Q4 2024.
• The 3-year median for Shares Issued is $4.1 million (2024), against an average of $4.0 million.
• Across the five-year window, Shares Issued retreated 20.93% in 2024 and surged 77.24% in 2025, its largest moves.
• Year by year, Shares Issued stood at $2.7 million in 2023, then dropped by 20.93% to $2.1 million in 2024, then jumped by 163.46% to $5.6 million in 2025.
• Per Business Quant, the three latest CTNM Shares Issued figures stand at $5.6 million (Q3 2025), $5.6 million (Q2 2025), and $5.1 million (Q1 2025).